Pharmacogenomic Testing for Psychiatric Medication in Arizona — Ordered and Reviewed by Telehealth
If you have had unusual side effects, or tried several medications without a good response, pharmacogenomic testing can explain part of why. It looks at the genes that control how your body processes common psychiatric medications, so the next choice is informed by your metabolism rather than trial and error. Sigmon Psychiatric orders pharmacogenomic testing for established patients across Arizona and reviews the results at a $179 visit by video. The laboratory bills the test itself separately.
At a glance: Online across Arizona: 5.0★ on Zocdoc across 88 verified reviews, $179 initial evaluation, and same-week openings often available.
What the test measures
A cheek swab is analyzed for variants in genes such as CYP2D6, CYP2C19, CYP1A2, and others that govern how quickly medications are broken down. Results group each medication into categories — for example, use as directed, use with caution, or consider an alternative — based on whether you are likely to clear it too fast (less effect at a normal dose) or too slowly (more side effects). Some panels also report variants linked to specific risks, such as HLA markers relevant to certain mood stabilizers.
The report covers most antidepressants, antipsychotics, mood stabilizers, ADHD medications, and anxiety and sleep medications in common use.
What it does not do
Pharmacogenomic testing does not identify the medication that will work best for you, and it does not diagnose anything. Professional guidelines treat it as one input alongside your history, symptoms, and prior medication trials. Angela uses it that way: a result that flags slow metabolism of one medication explains a bad experience and steers away from similar options, but the plan is still built on the clinical picture.
How testing works by telehealth in Arizona
- Decide together at a visit. Testing is discussed at an initial evaluation or follow-up, and ordered when it is likely to change a decision.
- Swab at home. The lab mails a kit to your Arizona address. You swab the inside of your cheek and return it in the prepaid envelope.
- Review results by video. Results arrive in roughly one to two weeks. A $179 results visit goes through the report and what it means for your current and future medications.
Cost and insurance
The results review is a $179 visit. The laboratory bills for the test directly; many commercial plans cover testing when prior medications have failed, and the major labs cap the patient's out-of-pocket amount, with self-pay prices typically in the low hundreds of dollars. Confirm the lab's exact charge before the kit is sent — the office will tell you which lab is used so you can call them. Medicare, Medicaid, and AHCCCS (Arizona Medicaid) are not accepted; patients with those plans are still welcome to book as self-pay.
Who should consider it
- Patients who have had strong side effects at ordinary doses
- Patients who have tried two or more medications for the same condition without benefit
- Patients taking several medications that interact through the same liver enzymes
- Patients who want this information before starting a long-term medication
New to the practice? Start with a $179 initial evaluation; testing can be ordered at that visit when appropriate.
Assessments and letters are outpatient services, not emergency care. If you or someone with you is in immediate danger, call 911. For a mental health crisis, call or text 988 or Arizona's statewide crisis line at 1-844-534-4673, both available 24 hours a day.
Ask about pharmacogenomic testing
Established patients can text (520) 650-5111 to request testing before the next visit. New patients can view current appointment times. See all assessments and prices.
Your provider: Angela Marton, PMHNP-BC
Angela Marton is a board-certified psychiatric mental health nurse practitioner providing telehealth psychiatric care to patients across Arizona. She specializes in medication management and comprehensive psychiatric evaluations for anxiety, depression, ADHD, and related conditions. Every visit is with the same provider. Same-week openings are often available, but timing varies; view current times when you book. More about Angela.
Insurance & costs
Pharmacogenomic (gene–drug) testing: $179 results visit; the lab bills the test separately, self-pay. HSA and FSA cards are accepted. All assessments and prices.
Commercial plans that may be accepted include Aetna, Blue Cross Blue Shield, Cigna, United Healthcare, Humana, Oscar Health, and Optum. Coverage and network participation vary by exact plan, so verify benefits before your visit. Self-pay rates are $179 for an initial evaluation and $129 for follow-up visits; HSA and FSA cards are accepted. Medicare, Medicaid, and AHCCCS (Arizona Medicaid) are not accepted; patients with those plans are still welcome to book as self-pay. Full insurance and pricing details.
Frequently asked questions
How much does pharmacogenomic testing cost?
The results review is a $179 visit. The test itself is billed by the laboratory, not by Sigmon Psychiatric; many labs bill commercial insurance and cap the patient's cost, and self-pay pricing is typically a few hundred dollars. Ask the lab for an exact quote before the swab is sent.
What does a pharmacogenomic test tell you?
How quickly your body metabolizes common antidepressants, antipsychotics, ADHD medications, and anxiety medications through liver enzymes such as CYP2D6 and CYP2C19, and whether certain gene variants raise side-effect risk. It does not say which medication will work best; it narrows the list of options that fit your metabolism.
Is gene testing done by telehealth?
Yes. The lab mails a cheek-swab kit to your Arizona address, you return it in the prepaid envelope, and results are reviewed with Angela by video, usually one to two weeks later.
Who should consider pharmacogenomic testing?
Patients who have had unusual side effects, who have tried two or more medications without a good response, or who want more information before starting treatment. It is an option, never a requirement, and the results are one input among many in a medication decision.